(Q53007016)

10 May 2018

title

Synergistic effects of thalidomide and poly (ADP-ribose) polymerase inhibition on type II collagen-induced arthritis in mice. (English)

1 reference

10 May 2018

0 references

H Kröger

1

1 reference

10 May 2018

R Miesel

2

1 reference

10 May 2018

A Dietrich

3

1 reference

10 May 2018

M Ohde

4

1 reference

10 May 2018

E Rajnavölgyi

5

1 reference

10 May 2018

H Ockenfels

6

1 reference

10 May 2018

publication date

1 April 1996

1 reference

10 May 2018

published in

Inflammation

1 reference

10 May 2018

volume

20

1 reference

10 May 2018

issue

2

1 reference

10 May 2018

page(s)

203-215

1 reference

10 May 2018

https://scigraph.springernature.com/pub.10.1007/bf01487406

exact match

0 references

cites work

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

1 reference

12 December 2020

Regulation by ADP-ribosylation

1 reference

12 December 2020

Chronic bullous disease of childhood and ulcerative colitis.

1 reference

12 December 2020

Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.

1 reference

12 December 2020

Role of ADP-ribosylation in endothelial signal transduction and prostacyclin production

1 reference

12 December 2020

Thalidomide: can it continue to be used?

1 reference

12 December 2020

Primed lymphocytes are boosted by type II collagen of their hosts after adoptive transfer.

1 reference

12 December 2020

Treatment of refractory rheumatoid arthritis--the thalidomide experience

1 reference

12 December 2020

Thalidomide--the need for a new clinical evaluation of an old drug.

1 reference

12 December 2020

Induction of arthritis in mice and rats by potassium peroxochromate and assessment of disease activity by whole blood chemiluminescence and 99mpertechnetate-imaging

1 reference

12 December 2020

Thalidomide--effect on T cell subsets as a possible mechanism of action

1 reference

12 December 2020

The production of antibodies to DNA in normal mice following immunization with poly(ADP-ribose).

1 reference

12 December 2020

Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates

1 reference

12 December 2020

Nicotinamide inhibits nitric oxide synthase mRNA induction in activated macrophages

1 reference

12 December 2020

Thalidomide inhibits the replication of human immunodeficiency virus type 1

1 reference

12 December 2020

Arthritogenicity of minor cartilage collagens (types IX and XI) in mice

1 reference

12 December 2020

Poly ADP-ribosylation of a 90-kDa protein is involved in TNF-alpha-mediated cytotoxicity

1 reference

12 December 2020

Assembly and activation of the NADPH:O2 oxidoreductase in human neutrophils after stimulation with phorbol myristate acetate

1 reference

12 December 2020

Total radical-trapping antioxidative capacity of plasma and whole blood chemiluminescence in patients with inflammatory and autoimmune rheumatic diseases

1 reference

12 December 2020

Induction of expression of genes encoding components of the respiratory burst oxidase during differentiation of human myeloid cell lines induced by tumor necrosis factor and gamma-interferon

1 reference

12 December 2020

Modulation of inflammatory arthritis by inhibition of poly(ADP ribose) polymerase

1 reference

12 December 2020

Collagen-induced arthritis in the mouse

1 reference

12 December 2020

Effect of procainamide and hydralazine on poly (ADP-ribosylation) in cell lines

1 reference

12 December 2020

The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies

1 reference

12 December 2020

Suppression of arthritis by an active center analogue of Cu2Zn2-superoxide dismutase.

1 reference

12 December 2020

Inhibitors of poly(ADP-ribose) polymerase increase antibody class switching

1 reference

12 December 2020

Preparation and characterization of the different types of collagen

1 reference

12 December 2020

Naturally-occurring antibodies to poly(ADP-ribose) in patients with systemic lupus erythematosus

1 reference

12 December 2020

Recent advances in cytokine therapy in leprosy

1 reference

12 December 2020

Enhancement of phorbol ester-induced production of tumor necrosis factor alpha by thalidomide

1 reference

12 December 2020

Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide

1 reference

12 December 2020

Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite

1 reference

12 December 2020

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

1 reference

12 December 2020

Lymphocyte dysfunction after DNA damage by toxic oxygen species. A model of immunodeficiency

1 reference

12 December 2020

Assessment of Collagen Type II Induced Arthritis in Mice by Whole Blood Chemiluminescence

1 reference

12 December 2020

[Poly-(ADP ribose) synthesis and regulation disorders in disease]

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01487406

1 reference

10 May 2018

1 reference

10 May 2018